165 related articles for article (PubMed ID: 15712218)
1. Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies.
Philip J; Dutta Roy S; Scally J; Foster CS; Javlé P
Prostate; 2005 Jul; 64(2):200-2. PubMed ID: 15712218
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
[TBL] [Abstract][Full Text] [Related]
3. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
4. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer.
Puppo P; Introini C; Calvi P; Naselli A
Eur Urol; 2006 May; 49(5):873-8. PubMed ID: 16439052
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
8. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies.
Radhakrishnan S; Dorkin TJ; Sheikh N; Greene DR
Prostate Cancer Prostatic Dis; 2004; 7(4):338-42. PubMed ID: 15365579
[TBL] [Abstract][Full Text] [Related]
9. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
Ploussard G; Dubosq F; Boublil V; Allory Y; de la Taille A; Vordos D; Hoznek A; Abbou CC; Salomon L
J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
[TBL] [Abstract][Full Text] [Related]
10. Altered prostate specific antigen reference range after transurethral resection of the prostate.
Wolff JM; Boekels O; Borchers H; Jakse G; Rohde D
Anticancer Res; 2000; 20(6D):4977-80. PubMed ID: 11326651
[TBL] [Abstract][Full Text] [Related]
11. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.
Dai B; Ye DW; Kong YY; Shen YJ; Wang BH
Asian J Androl; 2008 Mar; 10(2):325-31. PubMed ID: 18097514
[TBL] [Abstract][Full Text] [Related]
12. Prostate biopsy: who, how and when. An update.
Djavan B; Milani S; Remzi M
Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
[TBL] [Abstract][Full Text] [Related]
13. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
14. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M
Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491
[TBL] [Abstract][Full Text] [Related]
15. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
[TBL] [Abstract][Full Text] [Related]
16. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
Philip J; Hanchanale V; Foster CS; Javlé P
BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
[TBL] [Abstract][Full Text] [Related]
17. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
[TBL] [Abstract][Full Text] [Related]
18. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
D'Ambrosio DJ; Ruth K; Horwitz EM; Chen DY; Pollack A; Buyyounouski MK
Urology; 2008 May; 71(5):938-41. PubMed ID: 18279939
[TBL] [Abstract][Full Text] [Related]
19. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.
Palisaar JR; Wenske S; Sommerer F; Hinkel A; Noldus J
BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
